Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review - Wikidata - wikimedia - TriplyDB

Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review

Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review

http://www.wikidata.org/entity/Q28085414

about

Quantification of anticholinergic and sedative drug load with the Drug Burden Index: a review of outcomes and methodological quality of studies Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology.Optimizing medication appropriateness in older adults: a randomized clinical interventional trial to decrease anticholinergic burden.Anticholinergic Drug Burden in Noncancer Versus Cancer Patients Near the End of Life.Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease.The Influence of Patient Characteristics on Anticholinergic Events in Older People.Alternative Medications for Medications in the Use of High-Risk Medications in the Elderly and Potentially Harmful Drug-Disease Interactions in the Elderly Quality Measures.Hospitalizations Due to Adverse Drug Events in the Elderly-A Retrospective Register Study The Role of Pharmacists in Preventing Falls among America's Older Adults.Different methods, different results--how do available methods link a patient's anticholinergic load with adverse outcomes?The Association Between Anticholinergic Medication Burden and Health Related Outcomes in the 'Oldest Old': A Systematic Review of the Literature.The effects of antimuscarinic treatment on the cognition of spinal cord injured individuals with neurogenic lower urinary tract dysfunction: a prospective controlled before-and-after study.Anticholinergics: theoretical and clinical overview.Potentially Inappropriate Prescribing Among People with Dementia in Primary Care: A Retrospective Cross-Sectional Study Using the Enhanced Prescribing Database.Examination and Estimation of Anticholinergic Burden: Current Trends and Implications for Future Research.A Novel Scale Linking Potency and Dosage to Estimate Anticholinergic Exposure in Older Adults: the Muscarinic Acetylcholinergic Receptor ANTagonist Exposure Scale.Anticholinergic Exposure and Risk of Pneumonia in Persons with Alzheimer's Disease: A Nested Case-Control Study.Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders.The Impact of Medication Anticholinergic Burden on Cognitive Performance in People With Schizophrenia.Relationship between drug burden and physical and cognitive functions in a sample of nursing home patients with dementia.Measuring anticholinergic exposure in patients with dementia: A comparative study of nine anticholinergic risk scales.Medicines management in community settings: The role of the nurse.Association Between Anticholinergic Drug Use and Health-Related Quality of Life in Community-Dwelling Older Adults.Anticholinergic burden and dry mouth among Finnish, community-dwelling older adults.Role of anticholinergic burden in primary care patients with first cognitive complaints.Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan.Assessment, diagnosis and treatment of urinary incontinence in women.Anticholinergic burden in schizophrenia and ability to benefit from psychosocial treatment programmes: a 3-year prospective cohort study.The Screening of Anticholinergic Accumulation by Traditional Chinese Medicine.Atropinic (anticholinergic) burden in antipsychotic-treated patients.[Decision aids in complex polypharmacy : Medication data bases and counselling by clinical pharmacists].Anticholinergic burden and health outcomes among older adults discharged from hospital: results from the CRIME study.Optimizing pharmacotherapy in elderly patients: the role of pharmacists.The burden of central anticholinergic drugs increases pain and cognitive dysfunction. More knowledge about drug-interactions needed.Cutaneous Drug Reactions in the Elderly.Development of postoperative central anticholinergic syndrome due to low-dose intravenous fentanyl.Tolerability of buprenorphine transdermal system in nursing home patients with advanced dementia: a randomized, placebo-controlled trial (DEP.PAIN.DEM).Analysis of spatiotemporal pattern and quantification of gastrointestinal slow waves caused by anticholinergic drugs.The cholinergic system in the pathophysiology and treatment of Alzheimer's disease Anticholinergic burden and comorbidities in patients attending treatment with trospium chloride for overactive bladder in a real-life setting: results of a prospective non-interventional study

P2860

Q30240269-FF26644D-30BB-4D2C-A326-A7477926C8D0 Q31155412-1493D5C2-36EC-46C8-BE31-A4F4F22965A5 Q33721857-39F0F8E1-4B5A-4E78-9F95-57FB10067173 Q33802529-9B59CFFD-4C03-4E16-B3D9-092D4881B273 Q35944999-4ED21CF9-EF7B-44B2-BD64-8403C3AB1FAC Q36650690-F916414D-1202-4469-80C8-814F70FC62F9 Q36961194-DDA78EB3-E53B-483D-8362-6C681E7296E2 Q37312143-B698F24D-A0B1-44B4-964B-B1A0E4CC86C3 Q37402051-3F140FB6-456F-4FFE-AF1D-ABCAA0A88011 Q38583153-201B046F-DD07-4FEB-BE1E-EF3F658A43DC Q38600762-14327A3E-658B-42F1-AA5E-E90A1889E2DA Q38635232-24D1BE9B-8ADD-41F4-85AB-D408D2E891C0 Q38769800-E5DBB1DC-B30F-49A0-9D14-00630E15AB04 Q38881079-124BA9BB-61FD-49E9-87DA-4E72604CD754 Q38886942-2A0CF206-23F2-4D75-8936-2B40E3739B16 Q39019058-BB5E8B59-AA6A-4A2F-9926-041C3A6769C7 Q39136336-EF864380-DCA9-404D-A5DF-F077F70D4E50 Q41214474-50383D5C-CFA9-42CD-8FA9-35E177C0D824 Q47133877-AD9125C3-111C-422E-8CEB-A432F61E36A6 Q47162154-305EAF12-173C-43CB-BF21-DAEC335EBBF6 Q47559523-E90BAB67-8F22-4430-BB1E-E35B276E0718 Q47569297-6E04C907-258A-4DA2-B930-64C3E848773C Q47648971-205B7874-29AC-4F2D-B3AD-999829EADDA5 Q47682201-E1119223-27C3-4EC4-8654-021482E82163 Q47723092-1F06E125-04EB-4738-8891-C3B6A4E02F66 Q47741746-0E8FB2CF-6D70-4DD2-A8C7-DB3184C9C03F Q47814188-AC089AA0-6533-489A-8EC6-0E39AA87E8A9 Q47891971-EBFA5A4A-E6AF-41BF-AC29-C421FC87D992 Q47901868-74FA88D9-BB04-4C44-9C1D-5F4CF6BE255A Q48099199-267C3BB7-64E1-4EE9-88B1-4AB7E6E488C3 Q48105341-CB0AF75C-B476-45A3-B1FC-56D32E43F9C6 Q48308894-468C13C4-BE8D-4974-9379-CFC88DBDF17F Q49324777-EA648F95-EEB2-42E3-9063-BA1315852A3F Q50063290-CE6076D2-D020-4C75-B6CF-B210CDBC2068 Q51803601-D4193EA1-6395-473F-B07E-89659AFA6C0F Q53681320-74EEE9EC-7309-4545-9E0A-1BAD64A80DD3 Q54960408-465CEEE9-D4B9-460B-ABB2-BD82BC692394 Q54982279-1C759116-9340-4008-A0A6-2CA245EE19A7 Q57177786-D014E412-85C7-45A0-A93C-39D80FCFD3C5 Q58741609-423515B0-1B53-4F1C-95B7-A5F0606CC556

P2860

Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review

http://www.wikidata.org/entity/Q28085414

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Anticholinergic burden quantif ...... er people: a systematic review

@ast

Anticholinergic burden quantif ...... er people: a systematic review

@en

Anticholinergic burden quantif ...... er people: a systematic review

@nl

type

label

Anticholinergic burden quantif ...... er people: a systematic review

@ast

Anticholinergic burden quantif ...... er people: a systematic review

@en

Anticholinergic burden quantif ...... er people: a systematic review

@nl

prefLabel

Anticholinergic burden quantif ...... er people: a systematic review

@ast

Anticholinergic burden quantif ...... er people: a systematic review

@en

Anticholinergic burden quantif ...... er people: a systematic review

@nl

P1433

Q28085414-9CA8AE1C-1FED-4449-8C99-3B04DFE01886

P1476

Q28085414-7B00F6A8-EA5F-458B-B769-38F9D761E1CA

P2093

Q28085414-0D547500-94AD-4E75-8481-C5BB5E0619B2

Q28085414-47EB5B26-7B57-4BC7-AD1D-715588A5F71D

Q28085414-C1648417-572E-4241-B299-00D4D880784A

P275

Q28085414-E43E0213-5CB9-4DFD-B6BD-2611C88CC6C6

P2860

Q28085414-065702AE-EFBF-4349-A69F-67BBE7B63891

Q28085414-07766F4C-9ED1-4953-9E31-80AA38951027

Q28085414-0C5A749B-AA03-4E99-B5E2-0DE5230935E6

Q28085414-16F8D92E-155D-46B2-8E87-8612C7CE7472

Q28085414-189754A7-2BF2-443A-ABD6-8AA4AA0EC280

Q28085414-225FA8BA-9378-40D9-AF99-5DBFBCA5D2F4

Q28085414-28694934-04DF-4FE3-A58B-7934DFD83A1A

Q28085414-31392C0F-E985-4F2E-8E4E-CC050676761E

Q28085414-32752322-D44C-44BC-9C17-60FD2945F7E2

Q28085414-32CD211D-9252-4AA4-872B-C6E7B3009F5A

P2888

Q28085414-5A799461-9B88-4744-AE6D-6951BB0FABE6

P304

Q28085414-CE4CBDD1-9C4D-4D49-A6E6-0EC7AC640577

P31

Q28085414-14C3E4A3-8074-4DBC-BE02-960460839C70

Q28085414-4EE35DD2-D31C-426C-BF96-BF2FE3FA2DC4

Q28085414-6D458B54-0330-4215-B033-02AB696A08C2

P3181

Q28085414-B6F7840E-8884-4766-9E67-402637928F8A

P356

Q28085414-6BB8999D-0B9D-48D9-A780-918C6ECE776C

P407

Q28085414-FBD838EB-D122-481D-B32F-4F4828071DF3

P478

Q28085414-57305D50-E4C5-4588-B65A-46183DCD21A7

P577

Q28085414-1FBFDCC8-BDDA-4258-B0E1-3757D5CD7746

P5875

Q28085414-762066FF-FCF5-48D2-B0E6-0DAE341D96EB

P6179

Q28085414-32CAC167-7496-4827-B6D5-A6670D2DA060

P698

Q28085414-C324ABC4-704B-4F59-82E7-3FDA285C3E20

P921

Q28085414-7A04C24E-B56A-4533-A450-DCC73E19B0C0

Q28085414-C356440F-1F07-4CEE-B2BD-E6EDD98A5710

Q28085414-C94BE135-2359-4BCC-AE44-36089C1EF9B5

P932

Q28085414-A7ECCCD4-C70B-40DB-9B77-4E8E60E73243

P3181

P356

S12877-015-0029-9

P1433

P1476

Anticholinergic burden quantif ...... er people: a systematic review

@en

P2093

Mohammed Saji Salahudeen

http://www.w3.org/2001/XMLSchema#string

Prasad S Nishtala

http://www.w3.org/2001/XMLSchema#string

Stephen B Duffull

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homes.

Impact and recognition of cognitive impairment among hospitalized elders.

Drug-induced cognitive impairment in the elderly.

Acetylcholine and delirium.

Use of anticholinergics and the risk of cognitive impairment in an African American population

The impact of anticholinergic burden in Alzheimer's dementia-the LASER-AD study.

Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study.

Anticholinergic effects of medication in elderly patients.

Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study

Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline.

P2888

s12877-015-0029-9

P304

31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P3181

2603021

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/S12877-015-0029-9

http://www.w3.org/2001/XMLSchema#string

P407

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274253149

http://www.w3.org/2001/XMLSchema#string

P6179

1052742185

http://www.w3.org/2001/XMLSchema#string

P698

25879993

http://www.w3.org/2001/XMLSchema#string

P921

mechanism of action

P932

4377853

http://www.w3.org/2001/XMLSchema#string